Abstract: This disclosure relates to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.

Abstract: This disclosure related to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.

Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.

Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.

Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.

Abstract: This disclosure related to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.

Abstract: This disclosure relates to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.

Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.

Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.

Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.

Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.

Abstract: This disclosure relates to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.

Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.

Abstract: This disclosure relates to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.

Abstract: A telecommunication system includes a processor, interfaces in communication with the public telephone network and a data network, respectively, and a memory. The memory comprises executable instructions that when executed by the processor direct the system to controllably permit access to a teleconference bridge in response to a communication from a mobile-communication device that includes information responsive to a previously communicated license key. Generally, the communication is in the form of a call from the user of the mobile-communication device. Upon receipt of the call, the telecommunication system confirms that the mobile-communication device communicates a pass code that was included in an encrypted form in the license key.

Abstract: An anchor comprising a container having: a size of at least 3 m×3 m×3 m; a plurality of chambers; at least one valve in each chamber to selectively allow and prevent fluid communication between each chamber and a surrounding environment. Exemplary embodiments also include pressure release valves provided the chambers. The pressure release valves are adapted to allow transfer of fluid between the chamber and the environment when the pressure difference between the inside and outside of the chamber exceeds a predetermined level such as 0.5 bar or 1 bar; typically to allow fluid release from the chamber when the pressure inside the chamber exceeds the pressure outside the chamber by a predetermined level. A method of deploying and manufacturing are also disclosed.

Abstract: A telecommunication system includes a processor, interfaces in communication with the public telephone network and a data network, respectively, and a memory. The memory comprises executable instructions that when executed by the processor direct the system to controllably permit access to a teleconference bridge in response to a communication from a mobile-communication device that includes information responsive to a previously communicated license key. Generally, the communication is in the form of a call from the user of the mobile-communication device. Upon receipt of the call, the telecommunication system confirms that the mobile-communication device communicates a pass code that was included in an encrypted form in the license key.

Abstract: A telecommunication system includes a processor, interfaces in communication with the public telephone network and a data network, respectively, and a memory. The memory comprises executable instructions that when executed by the processor direct the system to controllably permit access to a teleconference bridge in response to a communication from a mobile-communication device that includes information responsive to a previously communicated license key. Generally, the communication is in the form of a call from the user of the mobile-communication device. Upon receipt of the call, the telecommunication system confirms that the mobile-communication device communicates a pass code that was included in an encrypted form in the license key.

Abstract: A system and method for providing a user with a customized data based on the user profile. A system comprises a server that collects electronic data based on the user profile. The server then generates a checksum of the collected data and sends it to the user. Based on the checksum, the user notifies the server of the data that has been previously sent. In response, the server sends to the user data that has not been previously sent to the user.

Abstract: A telecommunication system includes a processor, interfaces in communication with the public telephone network and a data network, respectively, and a memory. The memory comprises executable instructions that when executed by the processor direct the system to controllably permit access to a teleconference bridge in response to a communication from a mobile-communication device that includes information responsive to a previously communicated license key. Generally, the communication is in the form of a call from the user of the mobile-communication device. Upon receipt of the call, the telecommunication system confirms that the mobile-communication device communicates a pass code that was included in an encrypted form in the license key.